Skip to main content
. 2016 May 23;60(6):3821–3823. doi: 10.1128/AAC.00171-16

FIG 1.

FIG 1

Comparison of results between (A) Sanger sequencing and (B) next-generation sequencing of D0, D11, D34, and D35 patient samples. Percentage parasitemia is shown below each day (P:n%). Percentage sequence reads contributing to the specific atovaquone-proguanil resistance-associated loci in cytochrome b are shown on the y axis, and pretreatment (D0) and day of treatment failure samples (D11 to D35) are shown on the x axis.